The neuroleptic malignant syndrome.
D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000175:diagnosis; D002389:Catatonia / Q000175:diagnosis; D003937:Diagnosis, Differential; D005334:Fever / Q000139:chemically induced*; D006801:Humans; D009069:Movement Disorders / Q000139:chemically induced* / Q000175:diagnosis; D013577:Syndrome; D014474:Unconsciousness / Q000139:chemically induced
D014150:Antipsychotic Agents